Stem cell mobilization and transplantation represent pivotal advances in the management of multiple myeloma. This therapeutic approach involves stimulating the release of haematopoietic stem cells ...

The CEPHEUS trial is a trial for newly diagnosed multiple myeloma patients who are not eligible for stem cell transplantation, or in whom a transplant was deferred. And 395 patients were randomized ...

A diagnosis of acquired von Willebrand disease and stage 2 multiple myeloma followed unusual symptoms, leading to extensive testing. Treatment included a four-drug chemotherapy regimen and an ...

A blood and marrow transplant (BMT) is a treatment used for certain cancer types that works by resetting the body’s ability to make healthy blood cells. It does this by replacing damaged or destroyed ...

A study presented at the American Society of Hematology annual meeting explored how relationship dynamics, including satisfaction and strain, influence physical and emotional outcomes during ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Exicure, Inc. (XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed patient ...

A study reveals the gut microbiome's role in predicting multiple myeloma outcomes, highlighting butyrate-producing bacteria ...

Please provide your email address to receive an email when new articles are posted on . The addition of subcutaneous daratumumab to triplet therapy improved outcomes in transplant-ineligible or ...

Immune therapy linvoseltamab showed deep early responses in multiple myeloma, raising hopes some patients may avoid bone marrow transplants in future trials.

Treatment of symptomatic patients with newly diagnosed multiple myeloma (MM) is dictated by risk-stratification and eligibility for hematopoietic cell transplantation (HCT). Progression-free survival ...

Autologous stem cell transplantation (ASCT) is a critical treatment option for patients with multiple myeloma, a type of blood cancer. This procedure involves collecting a patient's own stem cells, ...